Pulmonary complications of sickle cell disease

Hemoglobin

Volumn 35, Issue 5-6, 2011, Pages 625-635

  Khoury, Ruby A ^a   Musallam, Khaled M ^a   Mroueh, Salman ^a   Abboud, Miguel R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Acute chest syndrome (ACS); Asthma; Pulmonary hypertension; Sickle cell disease

Indexed keywords

INTERLEUKIN 8; OXYGEN; SECRETORY PHOSPHOLIPASE A2;

ACUTE CHEST SYNDROME; ARTICLE; ASTHMA; BACTEREMIA; CHILDHOOD DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC LUNG DISEASE; CLOSTRIDIA; COUGHING; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENTEROBACTER; ENZYME BLOOD LEVEL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FAT EMBOLISM; FEVER; HAEMOPHILUS INFLUENZAE; HEMOLYSIS; LUNG ARTERY PRESSURE; LUNG COMPLICATION; LUNG EMBOLISM; LUNG FIBROSIS; LUNG INFECTION; LUNG INFILTRATE; LUNG SEQUESTRATION; MULTICENTER STUDY (TOPIC); MYCOPLASMA PNEUMONIAE; OXYGEN THERAPY; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; PULMONARY VEIN OBSTRUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SALMONELLA; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; TRICUSPID REGURGITANT JET VELOCITY; WHEEZING;

ACUTE CHEST SYNDROME; ANEMIA, SICKLE CELL; ASTHMA; HUMANS; HYPERTENSION, PULMONARY;

EID: 81055144339     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2011.621149     Document Type: Article

References (64)

1. Cavalli-Sforza LL, Menozzi P, Piazza A, Eds. The History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
2. Aliyu ZY, Gordeuk V, Sachdev V, et al. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol. 2008;83(6):485-490. (Pubitemid 351742798)
3. Noguchi CT, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. Bailliére's Clin Haematol. 1993;6(1):57-91. (Pubitemid 23144094)
4. Bailey K, Morris JS, Thomas P, Serjeant JR. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child. 1992;67(4):517-520.
5. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84(2):643-649. (Pubitemid 24215969)
6. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med. 1979;139(1):67-69. (Pubitemid 10131851)
7. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25): 1855-1865. (Pubitemid 30419049)
8. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Stud of Sickle Cell Disease. Blood. 1997;89(5):1787-1792. (Pubitemid 27097475)
9. Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. Am Rev Respir Dis. 1971;104(2):159-165.
10. Barrett-Connor, E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA. 1973;224(7):997-1000.
11. Tsolia MN, Psarras S, Bossios A, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004;39(5):681-686. (Pubitemid 39180441)
12. Apisarnthanarak A, Mundy LM. Etiology of community-acquired pneumonia. Clin Chest Med. 2005;26(1):47-55. (Pubitemid 40410702)
13. Vichinsky EP, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994;83(11):3107-3112. (Pubitemid 24158452)
14. Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000;96(9):3276-3278.
15. Ballas SK, Files SB, Luchtman-Jones L, et al. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006;30(2):165-170. (Pubitemid 43977317)
16. Styles LA, Abboud M, Larkin S, et al. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007;136(2):343-344. (Pubitemid 46020766)
17. Abboud MR, Taylor EC, Habib D, et al. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte stimulating factor asociated with the acute chest syndrome in sickle cell disease. Br J Hematol. 2000;111(2):482-490. (Pubitemid 32009340)
18. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333(11):699-703.
19. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317-1322.
20. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sicklecell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778): 663-1672.
21. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92(9):3082-3089. (Pubitemid 28492313)
22. Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol. 2010;85(1):24-28.
23. Strouse JJ, Takemoto CM, Keefer JR, et al. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer. 2008;50(5): 1006-1012. (Pubitemid 351500179)
24. Reagan MM, DeBaun MR, Frei-Jones MJ. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Pediatr Blood Cancer. 2011;56(2):262-266.
25. Miller ST, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001;139(6):785-789. (Pubitemid 34014456)
26. Hankins J, Jeng M, Harris S, et al. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol. 2005;27(3):158-161. (Pubitemid 40397247)
27. Collins FS, Orringer EP. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med. 1982;73(6):814-821. (Pubitemid 13211825)
28. Hayag-Barin JE, Smith RE, Tucker FC Jr. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. Am J Hematol. 1998;57(1):82-84. (Pubitemid 28047205)
29. Aeossopos A, Farmakis D, Karagiorga M, et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood. 2001;97(11):3411-3416.
30. Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood. 2003;101(4):1257-1261. (Pubitemid 36182493)
31. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-895. (Pubitemid 38252536)
32. Ataga KI, Sood N, De Gent G, et al. Pulmonary hypertension in sickle cell disease. Am J Med. 2004;117(9):665-669. (Pubitemid 40288173)
33. Sutton LL, Castro O, Cros DJ, et al. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74(6):626-628. (Pubitemid 124008670)
34. Dahoui HA, Hayek MN, Nietert PJ, et al. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010;54(3):398-402.
35. Minniti CP, Sable C, Campbell A, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica. 2009;94(3):340-347.
36. Gordeuk VR, Minniti CP, Nouraie M, et al. Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica. 2011;96(1):33-40.
37. Parent F, Bachir D, Inamo J, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365(1):44-53.
38. De Castro LM, Jonassaint JC, Graham FL, et al. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol. 2008;83(1):19-25.
39. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134(1):109-115. (Pubitemid 43830036)
40. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81-90. (Pubitemid 41002842)
41. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662. (Pubitemid 40471796)
42. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47. (Pubitemid 46110926)
43. Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol. 2005;129(4):449-464. (Pubitemid 40769895)
44. Morris CR, Galdwin MT, Kato GJ. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med. 2008;8(7):620-632.
45. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359(21):2254-2265.
46. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84(9):618-625.
47. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004;61(2):227-237. (Pubitemid 38091763)
48. Graido-Gonzalez E, Doherty JC, Bergreen EW, et al. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood. 1998;92(7):2551-2555. (Pubitemid 28453000)
49. Werdehoff SG, Moore RB, Hoff CJ, et al. Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. Am J Hematol. 1998;58(3): 195-199. (Pubitemid 28303547)
50. Bunn HF, Nathan DG, Dover GJ, et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood. 2010;116(5):687-692.
51. Machado RF, Barst RJ, Yovetich NA, et al. Safety and efficacy of sildenafil therapy for dopplerdefined pulmonary hypertension in patients with sickle cell disease: Preliminary results of the WALK PHaSST Clinical Trial (Proceedings of the 51st American Society of Hematology). Blood. 2009;114(22):(Abstract 571).
52. Minniti CP, Machado RF, Coles WA, et al. Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol. 2009;147(5):737-743.
53. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923-2927.
54. Bryant R. Asthma in the pediatric sickle cell patient with acute chest syndrome. J Pediatr Health Care. 2005;19(3):157-162. (Pubitemid 40616271)
55. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax. 2005;60(3):206-210. (Pubitemid 40380278)
56. An P, Barron-Casella EA, Strunk RC, et al. Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity. J Allergy Clin Immunol. 2011;127(6):1440-1446.
57. Bernaudin F, Strunk RC, Kamdem A, et al. Asthma is associated with acute chest syndrome, but not with an increased rate of hospitalization for pain among children in France with sickle cell anemia: a retrospective cohort study. Haematologica. 2008;93(12):1917-1918.
58. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 2007;92(8):1115-8. (Pubitemid 350144219)
59. Field JJ, DeBaun MR. Asthma and sickle cell disease: two distinct diseases or part of the same process? Hematology Am Soc Hematol Educ Program. 2009:45-53.
60. Klings ES, Wyszynski DF, Nolen VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med. 2006;173(11):1264-1269. (Pubitemid 43848398)
61. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease. Lung. 2010;188(6):499-504.
62. Koumbourlis AC, Lee DJ, Lee A. Longitudinal changes in lung function and somatic growth in children with sickle cell disease. Pediatr Pulmonol. 2007;42(6):483-488. (Pubitemid 46870378)
63. Koumbourlis AC, Hurlet-Jensen A, ByeMR. Lung function in infants with sickle cell disease. Pediatr Pulmonol. 1997;24(4):277-281. (Pubitemid 27484205)
64. Hijazi Z, Onadeko BO, Khadadah M, et al. Pulmonary function studies in children with sickle cell disease and elevated Hb F. Int J Clin Pract. 2005;59(2):163-167. (Pubitemid 40331215)